American Diabetes Association
Browse
- No file added yet -

Associations of High Body Mass Index and Excessive Gestational Weight Gain with Pregnancy Outcomes in Women with Type 1 Diabetes: A Systematic Review and Meta-analysis

Download (2.09 MB)
figure
posted on 2024-08-07, 16:13 authored by Nooria Atta, Anuli Ezeoke, Clive J. Petry, Laura C Kusinski, Claire L Meek

BACKGROUND

The increased risk of pregnancy complications in type 1 diabetes is mainly attributed to maternal hyperglycemia. However, it is unclear if other potentially-modifiable factors, also contribute to risk in this population.

PURPOSE

To assess if high body-mass-index (BMI) and excessive gestational-weight-gain (GWG) are associated with perinatal complications in type 1 diabetes.

DATA SOURCES

We searched MEDLINE, Embase, PubMed, Scopus, Web of Science and Cochrane databases to January 2024.

STUDY SELECTION

Studies examining associations between periconception BMI or GWG and perinatal complications in type 1 diabetes were included.

DATA EXTRACTION

We used a predesigned data extraction template to extract study data including year, country, sample size, participants’ characteristics, exposure and outcomes.

DATA SYNTHESIS

We included 29 studies (18,965 pregnancies; 1978-2019) in the meta-analysis. A 1kg/m2 /1kg increase in preconception BMI or GWG was associated with a 3% and 11% increase in perinatal complications respectively (BMI OR 1.03 (95%CI 1.01-1.06); GWG OR 1.11 (95%CI 1.04-1.18)). Preconception BMI ≥ 25kg/m2 or excessive GWG was associated with a 22% and 50% increase in perinatal complications respectively (BMI OR 1.22 (95%CI 1.11-1.34); GWG OR 1.50 (95%CI 1.31-1.73)).

BMI was associated with congenital malformation, preeclampsia, and neonatal-intensive-care-unit admission. Excessive GWG was associated with preeclampsia, Caesarean delivery, large-for-gestational-age and macrosomia.

LIMITATIONS

Retrospective study design, variable measurement for exposures /outcomes, small number of studies for some outcomes, no data from Asia and Africa.

CONCLUSIONS

Addressing maternal BMI pre-pregnancy and preventing excessive GWG should be key clinical priorities to improve outcomes in pregnant women with type 1 diabetes.


Funding

CLM is supported by the NIHR Leicester BRC, Diabetes UK through an intermediate clinical fellowship (17/0005712; ISRCTN number 90795724) and project grant (22/0006456); by JDRF (project grant #201310726) and the EFSD-Novo Nordisk Foundation Future Leader’s Award (NNF19SA058974). NA is supported by a CARA (Council for Academics At-Risk) fellowship and Rowan Williams Cambridge and Queens College Lisa Hall Scholarship. The funders did not play a role in the design or conduct of the research study.

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC